<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02566525</url>
  </required_header>
  <id_info>
    <org_study_id>2015-001</org_study_id>
    <nct_id>NCT02566525</nct_id>
  </id_info>
  <brief_title>CytoSorb Reduction of Free Hemoglobin During Cardiac Surgery</brief_title>
  <acronym>REFRESH</acronym>
  <official_title>CytoSorb Reduction of Free Hemoglobin During Cardiac Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CytoSorbents, Inc</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>CytoSorbents, Inc</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective, multi-center, randomized, feasibility clinical study. Subjects will be
      randomized in a 1:1 ratio to either standard of care (SOC) alone or standard of care and
      treatment with the CytoSorbÂ® device.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2015</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">October 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in plasma free hemoglobin</measure>
    <time_frame>From Start of cardiopulmonary bypass procedure and end of cardiopulmonary bypass procedure (e.g. approximately 3 hours)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Assessment of serious device related adverse events</measure>
    <time_frame>From time of enrollment through ICU discharge (e.g. ICU stay of approximately 4 days)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ventilator time</measure>
    <time_frame>From start of cardiopulmonary bypass procedure through ICU discharge (e.g. ICU stay of approximately 4 days)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time in the ICU</measure>
    <time_frame>From the end of cardiopulmonary bypass procedure through ICU discharge (e.g. ICU stay of approximately 4 days)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Days in the hospital</measure>
    <time_frame>From the end of the cardiopulmonary bypass procedure through hopsital discharge (e.g. ICU stay of approximately 4 days)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence/progression of Acute Kidney Injury</measure>
    <time_frame>From Baseline through ICU discharge (e.g. ICU stay of approximately 4 days)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mortality</measure>
    <time_frame>From time of enrollment through 30 days post procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse event rates</measure>
    <time_frame>through 30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vital signs</measure>
    <time_frame>From Baseline through ICU discharge (e.g. ICU stay of approximately 4 days)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety Laboratory assessments</measure>
    <time_frame>From Baseline through ICU discharge (e.g. ICU stay of approximately 4 days)</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">52</enrollment>
  <condition>Elective Cardiac Surgery</condition>
  <arm_group>
    <arm_group_label>CytoSorb Device</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Standard of care plus treatment with CytSorb device installed on the CPB machine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard of care</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CytoSorb</intervention_name>
    <description>Cytosorb device use during cardiopulmonary bypass</description>
    <arm_group_label>CytoSorb Device</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Elective, cardiac surgery requiring cardiopulmonary bypass with anticipated duration
             of &gt;180 minutes

        Exclusion Criteria:

          -  Platelet count &lt; 20,000/ uL

          -  Body mass index &lt;18

          -  Pregnant women

          -  Life expectancy of &lt;14 days

          -  End stage organ disease

          -  Active infection

          -  Undergoing cardiac transplant or ventricular assist device explant, isolated primary
             coronary artery bypass grafting (CABG) or single valve procedure

          -  Contraindication to anticoagulation with heparin

          -  Declined informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Steve Sisk, MSc Pharm</last_name>
    <role>Study Director</role>
    <affiliation>CytSorbents</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Kentucky</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Maryland</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baystate Medical</name>
      <address>
        <city>Springfield</city>
        <state>Massachusetts</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cooper University Hospital</name>
      <address>
        <city>Camden</city>
        <state>New Jersey</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Columbia University</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh Medical Center</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baylor College of Medicine</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 28, 2015</study_first_submitted>
  <study_first_submitted_qc>October 1, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 2, 2015</study_first_posted>
  <last_update_submitted>July 5, 2017</last_update_submitted>
  <last_update_submitted_qc>July 5, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>CytoSorb device</keyword>
  <keyword>Plasma free hemoglobin</keyword>
  <keyword>inflammation</keyword>
  <keyword>extracorporeal bypass</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

